SARAH ENDLEIN: Open Payments
NPI 1215689047 · WYANDOTTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,547 in 218 payments from 17 companies in 2025. Trend: 2023 $1,171 · 2024 $2,632 · 2025 $3,547
Food & beverage: $3,547
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $689 |
| Vanda Pharmaceuticals Inc. | 15 | $409 |
| Alkermes, Inc. | 16 | $339 |
| Corium, LLC | 17 | $313 |
| Supernus Pharmaceuticals, Inc. | 30 | $300 |
| ABBVIE INC. | 21 | $279 |
| Axsome Therapeutics, Inc. | 11 | $200 |
| Otsuka America Pharmaceutical, Inc. | 12 | $195 |
| Lundbeck LLC | 21 | $173 |
| Collegium Pharmaceutical, Inc. | 10 | $161 |
Products named: CAPLYTA, Azstarys, Qelbree, VRAYLAR, FANAPT, REXULTI, Auvelity, ARISTADA.
Industry payments across MI — which companies pay providers there.
